Page last updated: 2024-08-24

atorvastatin and Tachycardia, Ventricular

atorvastatin has been researched along with Tachycardia, Ventricular in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, J; Hu, X; Li, C1
Asrar Ul Haq, M; Mutha, V; Rudd, N; Subiakto, I; Van Gaal, WJ1
Cheng, W; Hu, H; Li, X; Shi, Y; Wang, Y; Xuan, Y; Xue, M; Yan, S; Yang, N; Yin, J1
He, XZ; Wan, XH; Wang, HY; Xue, JF; Zhong, QH; Zhou, SH2
Chedgy, F; Howlett, DC; Inglis, C1
Bernard, D; De Backer, G; De Bacquer, D; De Buyzere, M; De Sutter, J; Jordaens, L; Langlois, M; Matthys, K; Tavernier, R; Van de Veire, NR1

Trials

5 trial(s) available for atorvastatin and Tachycardia, Ventricular

ArticleYear
Effects of rosuvastatin and atorvastatin on nonsustained ventricular tachycardia in patients with ST-elevation myocardial infarction: a retrospective analysis.
    European journal of clinical pharmacology, 2018, Volume: 74, Issue:1

    Topics: Anticholesteremic Agents; Atorvastatin; Cohort Studies; Electrocardiography; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Rosuvastatin Calcium; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left

2018
Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarc
    Trials, 2014, Sep-07, Volume: 15

    Topics: Anti-Arrhythmia Agents; Atorvastatin; Benzazepines; Biomarkers; Clinical Protocols; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Emergencies; Femoral Neck Fractures; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Middle Aged; Myocardial Infarction; Orthopedic Procedures; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrroles; Research Design; Risk Factors; Severity of Illness Index; Tachycardia, Ventricular; Tomography, X-Ray Computed; Treatment Outcome; Victoria

2014
The effect of early and intensive statin therapy on ventricular premature beat or non-sustained ventricular tachycardia in patients with acute coronary syndrome.
    Cardiology journal, 2010, Volume: 17, Issue:4

    Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Chi-Square Distribution; China; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Risk Assessment; Risk Factors; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Premature Complexes

2010
The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome.
    Clinical cardiology, 2011, Volume: 34, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Anti-Arrhythmia Agents; Atorvastatin; Chi-Square Distribution; China; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Risk Assessment; Risk Factors; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Premature Complexes

2011
Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants.
    International journal of cardiology, 2006, Sep-10, Volume: 112, Issue:1

    Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Belgium; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Defibrillators, Implantable; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Greece; Heptanoic Acids; Humans; Inflammation; Inflammation Mediators; Lipids; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prevalence; Pyrroles; Research Design; Risk Factors; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation

2006

Other Studies

2 other study(ies) available for atorvastatin and Tachycardia, Ventricular

ArticleYear
Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction.
    Cardiovascular therapeutics, 2016, Volume: 34, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Arginase; Atorvastatin; Cells, Cultured; Disease Models, Animal; GAP-43 Protein; Heart; Interleukin-1beta; Macrophage Activation; Macrophages, Peritoneal; Male; Myocardial Infarction; Myocardium; Nerve Growth Factor; Nitric Oxide Synthase Type II; Phenotype; Rats, Wistar; Sympathetic Nervous System; Tachycardia, Ventricular; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase; Ventricular Fibrillation

2016
A case of recurrent ventricular tachycardia.
    BMJ (Clinical research ed.), 2011, Jun-01, Volume: 342

    Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin

2011